在肝硬化中治疗炎的最新进展
Tian Lan1,2, Ming Chen1,2, Chengwei Tang1,2
1Lab of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
United European gastroenterology journal
|February 10, 2024
概括
对硬化症的新疗法充满希望. 长期使用白蛋白,β-阻断剂和TIPS可能会改善生存率并减少炎的发生,尽管最佳使用需要进一步研究.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 是肝硬化的常见并发症,严重影响患者的预后.
- 门高血压的传统管理策略正在重新评估它们对炎的影响.
研究的目的:
- 审查近期在肝硬化患者中的管理方面的进展.
- 总结有关既有和新型治疗方法疗效的当前数据.
主要方法:
- 文献综述最近关于肝硬化中炎管理的研究.
- 分析了对白蛋白输注,β-阻断剂,横性肝内移植系统分流 (TIPS) 和炎的数据.
主要成果:
- 长期的阿尔伯明输液可能会提高患有炎的肝硬化患者的存活率.
- β-抑制剂显示出降低炎发病率的潜力.
- 横性肝内移植系统分流 (TIPS) 放置可以改善特定患者的存活率和风控制.
- 低流量酸为管理难治的酸提供了一个选择.
结论:
- 几种已建立的门高血压治疗方法在肝硬化中表现出前所未见的益处.
- 需要进一步的研究来优化使用白蛋白,β-阻断剂和TIPS,包括时间和技术方面,以改善患者的治疗结果.
相关概念视频
Pleural Effusion II: Symptoms and Management
174
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
174
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124
Esophageal Varices-I: Introduction
137
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
137
Diseases of the Liver and Gallbladder
538
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
538


